TARX (Tarsier Pharma) Operating Margin %: 0.00% (As of Dec. 2025)


What is Tarsier Pharma Operating Margin %?

Tarsier Pharma TARX Operating Margin % is 0.00% as of Dec. 2025.

Operating Margin % is calculated as Operating Income divided by its Revenue. Tarsier Pharma's Operating Income for the six months ended in Dec. 2025 was $-1.32 Mil. Tarsier Pharma's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Tarsier Pharma's Operating Margin % for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Tarsier Pharma's Operating Margin % or its related term are showing as below:


TARX's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -86.33
* Ranked among companies with meaningful Operating Margin % only.

Tarsier Pharma's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Tarsier Pharma's Operating Income for the six months ended in Dec. 2025 was $-1.32 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.55 Mil.

Tarsier Pharma  (NYSE:TARX) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.

Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Tarsier Pharma Operating Margin % Related Terms

Tarsier Pharma Operating Margin % Historical Data

* Premium members only.

The historical data trend for Tarsier Pharma's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsier Pharma Operating Margin % Chart

Tarsier Pharma Annual Data
Trend Dec23 Dec24 Dec25
Operating Margin %
0.00 0.00 0.00

Tarsier Pharma Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % 0.00 0.00 0.00 0.00 0.00

TARX vs : Operating Margin % Comparison

For the Biotechnology subindustry, Tarsier Pharma's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tarsier Pharma Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tarsier Pharma's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Tarsier Pharma's Operating Margin % falls into.


Tarsier Pharma Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Tarsier Pharma's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-2.554 / 0
= %

Tarsier Pharma's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-1.315 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Tarsier Pharma (TARX) has a Operating Margin % of 0.00% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Tarsier Pharma and its competitors.
Is Tarsier Pharma's Operating Margin % too high?
Tarsier Pharma's current Operating Margin % is 0.00%.
How does Tarsier Pharma's Operating Margin % compare to ?
Tarsier Pharma's Operating Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Tarsier Pharma and its competitors. Tarsier Pharma's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsier Pharma stock overvalued right now?
Tarsier Pharma (TARX) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Tarsier Pharma (TARX), the current Operating Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tarsier Pharma Business Description

Comparable Companies
Tarsier Pharma Ltd is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet needs in ocular diseases with underlying inflammatory pathologies. Its dazdotuftide platform technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. The company's Product Candidate Pipeline includes TRS01 and TRS02.